George K Ng's Net Worth
$411 Thousand
Who is George K Ng?
George K Ng does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Processa Pharmaceuticals, Inc., Sorrento Therapeutics, Inc., and Calidi Biotherapeutics, Inc..
SEC CIK
George K Ng's CIK is 0001638744
Past Insider Trading and Trends
2023 was George K Ng's most active year for acquiring shares with 4 total transactions. George K Ng's most active month to acquire stocks was the month of July. 2017 was George K Ng's most active year for disposing of shares, totalling 1 transactions. George K Ng's most active month to dispose stocks was the month of January. 2023 saw George K Ng paying a total of $50,000.00 for 1,000,000 shares, this is the most they've acquired in one year. In 2017 George K Ng cashed out on 40,000 shares for a total of $206,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Processa Pharmaceuticals, Inc. (PCSA) Snapshot price: $1.32
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +100.00% | 10K |
$2.70 | $27,000.00 | 20K |
Jan 30
| |||
Form 4
| +100.00% | 100K |
$0.25 | $25,000.00 | 200K |
Oct 12
| |||
Form 4
|
∞
| 100K |
$0.25 | $25,000.00 | 100K |
Oct 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sorrento Therapeutics, Inc. (SRNEQ) Snapshot price: $0.01
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +168.83% | 253.47K |
$9.95 | $895,500.00 | 403.6K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 4
| +181.08% | 89.34K |
—
|
—
| 138.68K |
Sep 11
| |||
Form 4
| -44.77% | -40.00K |
$5.15 | -$206,000.00 | 49.34K |
Feb 3
| |||
Form 4
| +10,060.59% | 89.34K |
—
|
—
| 90.23K |
Nov 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
∞
| 888 |
$13.50 | $11,989.52 | 888 |
Aug 21
| |||
Form 4
| +332.16% | 11.45K |
$11.50 | $131,709.50 | 14.9K |
Aug 3
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Calidi Biotherapeutics, Inc. (CLDI) Snapshot price: $1.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kintara Therapeutics, Inc. (HURA) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||